Cargando…

Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?

Pancreatic cancer is an aggressive malignancy with increasing incidence. Pancreatic ductal adenocarcinoma (PDAC) accounts for > 90% of pancreatic cancer diagnoses, while other exocrine tumors are much rarer. In this review, we have focused on two rare cancers of the exocrine pancreas: adenosquamo...

Descripción completa

Detalles Bibliográficos
Autores principales: Skorupan, Nebojsa, Ghabra, Shadin, Maldonado, J. Alberto, Zhang, Yang, Alewine, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400043/
https://www.ncbi.nlm.nih.gov/pubmed/37538977
http://dx.doi.org/10.20517/2394-4722.2022.106